Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01362686 · ClinicalTrials.gov registry record · NA
Comparative Research of Alzheimer's Disease Drugs
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01362686 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 200 participants.
The verdict
NCT01362686, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.
Interventions
- DRUG Rivastigmine
- DRUG Donepezil
- DRUG Galantamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01362686
The ClinicalTrials.gov registry entry for NCT01362686 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rivastigmine is the first listed.
NCT01362686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01362686 about?
NCT01362686 is a clinical study titled "Comparative Research of Alzheimer's Disease Drugs". Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.
What is the current status of trial NCT01362686?
This trial is currently terminated. It is a NA study. The enrollment target is 200 participants. The study started on 2011-04. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01362686?
The interventions under investigation include: Rivastigmine (DRUG), Donepezil (DRUG), Galantamine (DRUG).
Who is sponsoring clinical trial NCT01362686?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.